Up to two postdoctoral fellows are now available at Shiraz Institute for Cancer Research under supervision of Dr. Ghaderi, ICR director. For more information, please contact to Dr. Ghaderi at ghaderia@sums.ac.ir

Journal Clubs and Seminars

The journal clubs or seminars meet regularly every two weeks for one hour, 8:30-9:30 A.M. on Sunday in lecture room, to review current research about clinical practice especially in the field of cancer research. ...

Highly cited papers


1. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit (71 citations)
2. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. (64 citations)

2. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma (63 citations)

3. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express .... (60 citations)

4. CTLA4 gene variants in autoimmunity and cancer: A comparative review. (36 citations)

5. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers (35 citations)

 

1. Abtahi S, Asadipour M, Ghaderi A. The Legacy of Mesenchymal Stem Cells in Vindicating the Clonal Evolution Model of Cancer. Asian Pacific journal of cancer prevention : APJCP. 2018;19(8):2029-30.

 2. Mehdipour F, Razmkhah M, Rezaeifard S, Bagheri M, Talei AR, Khalatbari B, et al. Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes. Cell biology international. 2018. doi: 10.1002/cbin.11062
 
3.  Ghaderi F, Ahmadvand S, Ramezani A, Montazer M, Ghaderi A. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line. Biochemical and biophysical research communications. 2018;505(1):181-6.

4. Faghih Z, Deihimi S, Talei A, Ghaderi A, Erfani N. Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer. Cancer biomarkers : section A of Disease markers. 2018;22(4):733-45.

5.  Razmkhah M, Abtahi S, Ghaderi A. Mesenchymal stem cells, immune cells and tumor cells cross talk: A sinister triangle in the tumor microenvironment. Current stem cell research & therapy. 2018.
doi: 10.2174/1574888X13666180816114809